Loading clinical trials...
Loading clinical trials...
The dilation of perivascular spaces can be the result of various etiopathogenetic processes. White matter atrophy can cause enlargement of these perivascular spaces (PVS) but also obstruction of fluid...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
IRCCS Eugenio Medea
NCT03333200 · MLD, Krabbe Disease, and more
NCT05757141 · Vanishing White Matter Disease
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT07108712 · Diffusion Magnetic Resonance Imaging, Brain White Matter Diseases
NCT04753970 · Cerebral Small Vessel Diseases, Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy, and more
Scientific Institute IRCCS Eugenio Medea
Bosisio Parini, Lecco
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions